Rocket Pharma appoints Sarbani Chaudhuri as Chief Commercial & Medical Affairs Officer

ROCKET PHARMACEUTICALS, INC.

Annual base salary of $525,000 with a target bonus of 45% of salary.
Equity grant of ~$2,500,000 (50% options, 50% RSUs) vesting over three years.
One-third of RSUs/options vest at first anniversary; remainder over two years quarterly.
Sign-on bonus of $100,000 payable 30 days after start date, contingent on employment.
Severance of 9 months salary plus COBRA; 12 months salary/bonus/COBRA on qualifying change-in-control termination.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Sarbani Chaudhuri

Chief Commercial & Medical Affairs Officer

RCKT · ROCKET PHARMACEUTICALS, INC.

Effective: 2025-04-07
Filed: April 7, 2025, 7:59 PM ET

On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sarbani Chaudhuri was appointed as Chief Commercial & Medical Affairs Officer at ROCKET PHARMACEUTICALS, INC..

Action: appointed
Role: Chief Commercial & Medical Affairs Officer

Exact text from the filing

On April 7, 2025, Sarbani Chaudhuri was appointed by Rocket Pharmaceuticals, Inc. (the “Company”) as the Company’s Chief Commercial & Medical Affairs Officer.

View on SEC.gov

ROCKET PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR

accession 0001140361-25-012621

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.